OKN4395 An investigational EP2, EP4, and DP1 inhibitor in Phase 1 development for advanced solid tumors through Owkin affiliate Epkin.
Visit productCosigns Received
Be the first Cosign
Put your name behind OKN4395.
Add it to your Products I use list and share why you use it.